Ten-year clinical outcomes in >1000 node-negative (N0) Estrogen Receptor (ER)+ breast cancer (BC) patients (Pts) where treatment decisions incorporated the Recurrence Score Results: a registry analysis using TAILORx categorization. (March 2019) - Stemmer, S.M.; Leviov, M.; Tokar, M.; Ben-Baruch, N.; Uziely, B.; Fried, G.; Rosengarten, O.; Itay, A.; Nisenbaum, B.; Shak, S.